Innovitro Overview
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$7.58K
- Investors
-
2
Innovitro General Information
Description
Developer of cell-based allergy tests based in Gothenburg, Sweden. The company focuses on providing an animal-free way of determining the sensitizing potency of chemicals based on the response of skin cell lines to exposure to the chemicals.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
- Erik Dahlbergsgatan 11A
- 2nd Floor
- SE-411 26 Gothenburg
- Sweden
+46 070-713 00 00
Innovitro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 01-Jan-2013 | $7.58K | 00.000 | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2009 | 00.000 | 00.000 | Completed | Startup |
Innovitro Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Swedish Fund for Research without Animal Experiments | Other | 000 0000 | 000000 0 | ||
| GU Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |